Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002806 · ClinicalTrials.gov registry record · Phase 2
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma
A Phase 2 study, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- Phase 2
- Development phase
- 43
- Enrollment target
NCT00002806 is a Phase 2 study that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 43 participants.
The verdict
NCT00002806, a Phase 2 study, has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 43 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining radiation therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of procarbazine, lomustine, and vincristine followed by radiation therapy in treating adults who have supratentorial glioma.
Interventions
- DRUG vincristine sulfate
- DRUG lomustine
- DRUG procarbazine hydrochloride
- RADIATION low-LET photon therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 1996-07 |
| Est. Completion | 2004-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002806
The ClinicalTrials.gov registry entry for NCT00002806 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which vincristine sulfate is the first listed.
NCT00002806 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002806 about?
NCT00002806 is a clinical study titled "Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining radiation therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase II trial to study the effe...
What is the current status of trial NCT00002806?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 43 participants. The study started on 1996-07. Estimated completion is 2004-07.
What interventions are being tested in trial NCT00002806?
The interventions under investigation include: vincristine sulfate (DRUG), lomustine (DRUG), procarbazine hydrochloride (DRUG), low-LET photon therapy (RADIATION).
Who is sponsoring clinical trial NCT00002806?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.